Whiz Partners
Tokyo-based investment firm that invests via sponsored limited partnership funds. Public disclosures show repeated investments in healthcare, pharmaceuticals and life-science companies and selective investments in technology/game software businesses. The firm provides capital through fund vehicles and supports portfolio companies with business development and overseas expansion activities (notably China market support in disclosed cases).
Services
Equity investments via fund vehicles
Makes equity investments using sponsored investment limited partnerships (example funds: Whiz HealthCare Japan 2.0; Whiz Asia Evolution Fund).
Business development and overseas expansion support
Provides strategic support to portfolio companies for business development and overseas market entry (example: support for CRI Middleware's China expansion and partnership facilitation).
Support for partnership, M&A and capital participation
Uses investment funds to support partnerships, M&A, and capital participation in collaboration partners to accelerate portfolio growth.
Equity investments via fund vehicles
Makes equity investments using sponsored investment limited partnerships (example funds: Whiz HealthCare Japan 2.0; Whiz Asia Evolution Fund).
Business development and overseas expansion support
Provides strategic support to portfolio companies for business development and overseas market entry (example: support for CRI Middleware's China expansion and partnership facilitation).
Support for partnership, M&A and capital participation
Uses investment funds to support partnerships, M&A, and capital participation in collaboration partners to accelerate portfolio growth.
Portfolio
Investment agreement dated 2015-09-18; listed on Mothers (code 4571) according to disclosure.
#Biotechnology / Drug delivery
Investment agreement dated 2015-09-29; listed on Mothers (code 2370) per disclosure.
#Healthcare / Medical devices or related services
MOU and strategic partnership with Shanghai Oriental Pearl Media announced 2015-11-12; disclosed fund investment enabled approx. JPY 880 million capital raise.
#Game development middleware / Software
Investment agreement dated 2016-04-06; listed on JASDAQ (code 4582) per disclosure.
#Pharmaceuticals
Investment agreement dated 2016-05-13; listed on TSE 1st Section (code 3676) per disclosure.
#Technology / Services (company disclosure)
Investment agreement dated 2015-09-18; listed on Mothers (code 4571) according to disclosure.
#Biotechnology / Drug delivery
Investment agreement dated 2015-09-29; listed on Mothers (code 2370) per disclosure.
#Healthcare / Medical devices or related services
MOU and strategic partnership with Shanghai Oriental Pearl Media announced 2015-11-12; disclosed fund investment enabled approx. JPY 880 million capital raise.
#Game development middleware / Software
Investment agreement dated 2016-04-06; listed on JASDAQ (code 4582) per disclosure.
#Pharmaceuticals
Investment agreement dated 2016-05-13; listed on TSE 1st Section (code 3676) per disclosure.
#Technology / Services (company disclosure)